These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 24447617)

  • 1. The simplified reference tissue model with 18F-fallypride positron emission tomography: choice of reference region.
    Ishibashi K; Robertson CL; Mandelkern MA; Morgan AT; London ED
    Mol Imaging; 2013; 12(8):. PubMed ID: 24447617
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Surrogate markers for cerebral blood flow correlate with [¹⁸F]-fallypride binding potential at dopamine D(2/3) receptors in human striatum.
    Cumming P; Xiong G; la Fougère C; Rominger A; Bartenstein P; Buchholz HG; Piel M; Rösch F; Gründer G; Vernaleken I
    Synapse; 2013 Apr; 67(4):199-203. PubMed ID: 23239525
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preliminary assessment of extrastriatal dopamine D-2 receptor binding in the rodent and nonhuman primate brains using the high affinity radioligand, 18F-fallypride.
    Mukherjee J; Yang ZY; Brown T; Lew R; Wernick M; Ouyang X; Yasillo N; Chen CT; Mintzer R; Cooper M
    Nucl Med Biol; 1999 Jul; 26(5):519-27. PubMed ID: 10473190
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantification of dopamine D(2/3) receptors in rat brain using factor analysis corrected [18F]Fallypride images.
    Millet P; Moulin-Sallanon M; Tournier BB; Dumas N; Charnay Y; Ibáñez V; Ginovart N
    Neuroimage; 2012 Sep; 62(3):1455-68. PubMed ID: 22659483
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Brain imaging of 18F-fallypride in normal volunteers: blood analysis, distribution, test-retest studies, and preliminary assessment of sensitivity to aging effects on dopamine D-2/D-3 receptors.
    Mukherjee J; Christian BT; Dunigan KA; Shi B; Narayanan TK; Satter M; Mantil J
    Synapse; 2002 Dec; 46(3):170-88. PubMed ID: 12325044
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High-affinity dopamine D2/D3 PET radioligands 18F-fallypride and 11C-FLB457: a comparison of kinetics in extrastriatal regions using a multiple-injection protocol.
    Vandehey NT; Moirano JM; Converse AK; Holden JE; Mukherjee J; Murali D; Nickles RJ; Davidson RJ; Schneider ML; Christian BT
    J Cereb Blood Flow Metab; 2010 May; 30(5):994-1007. PubMed ID: 20040928
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Positron emission tomography imaging of amphetamine-induced dopamine release in the human cortex: a comparative evaluation of the high affinity dopamine D2/3 radiotracers [11C]FLB 457 and [11C]fallypride.
    Narendran R; Frankle WG; Mason NS; Rabiner EA; Gunn RN; Searle GE; Vora S; Litschge M; Kendro S; Cooper TB; Mathis CA; Laruelle M
    Synapse; 2009 Jun; 63(6):447-61. PubMed ID: 19217025
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Striatal and extrastriatal microPET imaging of D2/D3 dopamine receptors in rat brain with [¹⁸F]fallypride and [¹⁸F]desmethoxyfallypride.
    Constantinescu CC; Coleman RA; Pan ML; Mukherjee J
    Synapse; 2011 Aug; 65(8):778-87. PubMed ID: 21218455
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Spinal cord dopamine D2/D3 receptors: in vivo and ex vivo imaging in the rat using (18)F/(11)C-fallypride.
    Kaur J; Khararjian A; Coleman RA; Constantinescu CC; Pan ML; Mukherjee J
    Nucl Med Biol; 2014; 41(10):841-7. PubMed ID: 25199843
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low Dopamine D2/D3 Receptor Availability is Associated with Steep Discounting of Delayed Rewards in Methamphetamine Dependence.
    Ballard ME; Mandelkern MA; Monterosso JR; Hsu E; Robertson CL; Ishibashi K; Dean AC; London ED
    Int J Neuropsychopharmacol; 2015 Jan; 18(7):pyu119. PubMed ID: 25603861
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Decreased dopamine D2/D3-receptor binding in temporal lobe epilepsy: an [18F]fallypride PET study.
    Werhahn KJ; Landvogt C; Klimpe S; Buchholz HG; Yakushev I; Siessmeier T; Müller-Forell W; Piel M; Rösch F; Glaser M; Schreckenberger M; Bartenstein P
    Epilepsia; 2006 Aug; 47(8):1392-6. PubMed ID: 16922886
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Striatal and extrastriatal dopamine D2/D3 receptors in schizophrenia evaluated with [18F]fallypride positron emission tomography.
    Kegeles LS; Slifstein M; Xu X; Urban N; Thompson JL; Moadel T; Harkavy-Friedman JM; Gil R; Laruelle M; Abi-Dargham A
    Biol Psychiatry; 2010 Oct; 68(7):634-41. PubMed ID: 20673873
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Striatal and extrastriatal D2/D3-receptor-binding properties of ziprasidone: a positron emission tomography study with [18F]Fallypride and [11C]raclopride (D2/D3-receptor occupancy of ziprasidone).
    Vernaleken I; Fellows C; Janouschek H; Bröcheler A; Veselinovic T; Landvogt C; Boy C; Buchholz HG; Spreckelmeyer K; Bartenstein P; Cumming P; Hiemke C; Rösch F; Schäfer W; Wong DF; Gründer G
    J Clin Psychopharmacol; 2008 Dec; 28(6):608-17. PubMed ID: 19011428
    [TBL] [Abstract][Full Text] [Related]  

  • 14. D2/D3 dopamine receptor binding with [F-18]fallypride in thalamus and cortex of patients with schizophrenia.
    Buchsbaum MS; Christian BT; Lehrer DS; Narayanan TK; Shi B; Mantil J; Kemether E; Oakes TR; Mukherjee J
    Schizophr Res; 2006 Jul; 85(1-3):232-44. PubMed ID: 16713185
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [18F]Fallypride PET measurement of striatal and extrastriatal dopamine D 2/3 receptor availability in recently abstinent alcoholics.
    Rominger A; Cumming P; Xiong G; Koller G; Böning G; Wulff M; Zwergal A; Förster S; Reilhac A; Munk O; Soyka M; Wängler B; Bartenstein P; la Fougère C; Pogarell O
    Addict Biol; 2012 Mar; 17(2):490-503. PubMed ID: 22023291
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [123I]epidepride binding to cerebellar dopamine D2/D3 receptors is displaceable: implications for the use of cerebellum as a reference region.
    Pinborg LH; Videbaek C; Ziebell M; Mackeprang T; Friberg L; Rasmussen H; Knudsen GM; Glenthoj BY
    Neuroimage; 2007 Feb; 34(4):1450-3. PubMed ID: 17175177
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Striatal and extrastriatal dopamine release in the common marmoset brain measured by positron emission tomography and [(18)F]fallypride.
    Ota M; Ogawa S; Kato K; Masuda C; Kunugi H
    Neurosci Res; 2015 Dec; 101():1-5. PubMed ID: 26232153
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Small effect of dopamine release and no effect of dopamine depletion on [18F]fallypride binding in healthy humans.
    Cropley VL; Innis RB; Nathan PJ; Brown AK; Sangare JL; Lerner A; Ryu YH; Sprague KE; Pike VW; Fujita M
    Synapse; 2008 Jun; 62(6):399-408. PubMed ID: 18361438
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Measuring dopamine neuromodulation in the thalamus: using [F-18]fallypride PET to study dopamine release during a spatial attention task.
    Christian BT; Lehrer DS; Shi B; Narayanan TK; Strohmeyer PS; Buchsbaum MS; Mantil JC
    Neuroimage; 2006 May; 31(1):139-52. PubMed ID: 16469510
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vivo affinity of [18F]fallypride for striatal and extrastriatal dopamine D2 receptors in nonhuman primates.
    Slifstein M; Hwang DR; Huang Y; Guo N; Sudo Y; Narendran R; Talbot P; Laruelle M
    Psychopharmacology (Berl); 2004 Sep; 175(3):274-86. PubMed ID: 15024551
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.